RSS-affiliated body welcomes govt decision on prices of stents

Image
Press Trust of India New Delhi
Last Updated : Feb 13 2018 | 9:45 PM IST
The RSS-affiliated Swadeshi Jagran Manch (SJM) has welcomed the government's decision to keep intact the price cap on coronary stents, and demanded that prices of all medical devices categorised as drugs be regulated.
Prices of devices such as catheters, balloons and guidewires should be immediately regulated as the trade margins of these devices are extraordinarily high and they should be made affordable for the general public, SJM's co- convener Ashwani Mahajan said in a statement.
SJM congratulated the National Pharmaceutical Pricing Authority (NPPA) and the government for the decision to keep intact the price cap on coronary stents.
There is a need to make all medical devices more affordable to the masses in tune with the government's repeated commitment in this direction, Mahajan said.
Earlier, SJM had written to Prime Minister Narendra Modi and Union Minister Ananth Kumar requesting for a downward revision of prices of medical devices including stents.
Yesterday, the drug prices regulator marginally revised the ceiling prices of bare metal stents and drug eluting ones, while keeping the stents under price regulation regime.
A coronary stent is a tube-shaped device placed in the arteries that supply blood to the heart. It keeps the arteries open in the treatment of coronary heart diseases.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 13 2018 | 9:45 PM IST

Next Story